Style | Citing Format |
---|---|
MLA | Darvishi B, et al.. "Matrix Stiffening and Acquired Resistance to Chemotherapy: Concepts and Clinical Significance." British Journal of Cancer, vol. 126, no. 9, 2022, pp. 1253-1263. |
APA | Darvishi B, Eisavand MR, Majidzadeha K, Farahmand L (2022). Matrix Stiffening and Acquired Resistance to Chemotherapy: Concepts and Clinical Significance. British Journal of Cancer, 126(9), 1253-1263. |
Chicago | Darvishi B, Eisavand MR, Majidzadeha K, Farahmand L. "Matrix Stiffening and Acquired Resistance to Chemotherapy: Concepts and Clinical Significance." British Journal of Cancer 126, no. 9 (2022): 1253-1263. |
Harvard | Darvishi B et al. (2022) 'Matrix Stiffening and Acquired Resistance to Chemotherapy: Concepts and Clinical Significance', British Journal of Cancer, 126(9), pp. 1253-1263. |
Vancouver | Darvishi B, Eisavand MR, Majidzadeha K, Farahmand L. Matrix Stiffening and Acquired Resistance to Chemotherapy: Concepts and Clinical Significance. British Journal of Cancer. 2022;126(9):1253-1263. |
BibTex | @article{ author = {Darvishi B and Eisavand MR and Majidzadeha K and Farahmand L}, title = {Matrix Stiffening and Acquired Resistance to Chemotherapy: Concepts and Clinical Significance}, journal = {British Journal of Cancer}, volume = {126}, number = {9}, pages = {1253-1263}, year = {2022} } |
RIS | TY - JOUR AU - Darvishi B AU - Eisavand MR AU - Majidzadeha K AU - Farahmand L TI - Matrix Stiffening and Acquired Resistance to Chemotherapy: Concepts and Clinical Significance JO - British Journal of Cancer VL - 126 IS - 9 SP - 1253 EP - 1263 PY - 2022 ER - |